γ-synuclein Antibodies

Santa Cruz Biotechnology delivers a wide array of γ-synuclein monoclonal antibodies for research focused on understanding this important neurological protein. γ-synuclein monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). γ-synuclein is a member of the synuclein family and is primarily expressed in the nervous system, where it is implicated in neurodegenerative diseases such as Parkinson's disease and multiple system atrophy. γ-synuclein plays a role in synaptic function and neurotransmitter release, making it a critical target for understanding synaptic pathology. The study of γ-synuclein is essential for elucidating the mechanisms underlying neurodegeneration and developing potential therapeutic strategies. Research into γ-synuclein expression patterns and interactions continues to reveal new insights about its function in both healthy and diseased states. Understanding the molecular mechanisms of γ-synuclein can lead to breakthroughs in treating neurological disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of γ-synuclein's role in neurological health and disease.